July 2025
Length: 25:40 min.
In this episode, we dive into a timely study exploring the impact of perioperative glucagon-like peptide-1 (GLP-1) agonist use on pseudarthrosis rates following single-level lumbar fusion. Could a medication primarily used for diabetes and weight loss influence spinal fusion outcomes? Join guests Konstantinos Margetis and Stephen Kalhorn as they unpack the data from this large retrospective cohort study, discuss potential mechanisms, and consider how this might change perioperative management for spine patients.
Click here to read journal article
Click here to access CME activity